Novo Nordisk - Europe's most valuable company?

GLP-1 is balancing between strong growth and price erosion. Falling prices are rapidly increasing demand and sales, but at the same time, the product’s gross margin is naturally decreasing.

Ultimately, this is a long game. Through a strong increase in production volumes, unit costs can be brought down, even if gross margins have to be compromised. However, this provides a head start against future competitors, as entering the market becomes more difficult due to the price erosion.

6 Likes